Broussy, S.
Rouanet, F.
Lesaine, E.
Domecq, S.
Kret, M.
Maugeais, M.
Aly, F.
Dehail, P.
Bénard, A.
Wittwer, J.
Salamon, R.
Sibon, I.
Saillour-Glenisson, F.
Funding for this research was provided by:
Direction Générale de l’offre de Soins (PREPS-16-0124)
Article History
Received: 28 August 2019
Accepted: 10 September 2019
First Online: 29 October 2019
Ethics approval and consent to participate
: The PAPASéPA study protocol was approved on 23 102,018 by institutional review boards and Ethics Committees (Comité de Protection des Personnes Ile de France IV - CPP number: 2018-A01919–46; Commission Nationales Informatique et Libertés - CNIL authorization number DR-2019-088) and registered in ExternalRef removed (registration number: NCT 03865173).Patient consent has to be collected orally according to the CPP Ethics committee. Patients are invited verbally to participate. Their non-opposition has to be recorded in the medical file of the investigating centre. They may, at any time, object to the use of his or her data for research purposes, as explained in the information sheets they receive at inclusion.
: Not applicable
: The authors declare that they have no competing interests.